Análisis de la mutación D614G en secuencia del genoma completo de SARS-CoV-2 en El Salvador
Keywords:
SARS-CoV-2, D614G, mutación, 2019-nCoV, COVID-19Abstract
Introduction. The genome sequencing of indigenous samples of SARS-Cov-2 was carry out in October 2020. Objective. To analyze in silico the detected mutation in the isolated sequencies in El Salvador. Methodology. The sequencies were analyzed using the SOPHiA-DDM-V5.7.10 bioinformatic platform; the platform Nexclade beta v0.8.1 was used for the determination of variants due to missense mutation; the indigenous protein S (D614: PDB ID: 6VXX), was visualized and compared as well as the one from the mutant variant (D614G: PDB ID: 6XS6); Pymol-v1.7.2.3. was used in modeling and imaging generation of the proteins’ molecular details. Results. The analysis of the wild protein S crystals and the mutant ones, show differences at molecular level, including the loss of interactions between the residue G614 of the S1 domain and the threonine 859 of the S2 domain, favoring in such manner, the open configuration of the protein S, which is necessary for the interaction between S with the ACE2 receptor. Conclusion. The global dominance of the D614G and the bioinformatic and laboratory evidences published up to date, show a possible higher infectivity and transmissibility conferred by the variant D614G detected in the sequence of SARS-Cov-2 in El Salvador
Downloads
References
Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J et al. Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States. Emerging Infectious Diseases. 2020;26(6):1266-1273. DOI:10.3201/EID2606.200516
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States. N. Engl. J. Med. 2020;382(10):929–936. doi:10.1056/nejmoa2001191
Gobierno de El Salvador. COVID-19 Reporte Diario. Gobierno de la Republica de El Salvador. 2021. Fecha de consulta: 21 de enero de 2021. Disponible en: https:// covid19.gob.sv/diarios/
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269. doi:10.1038/ s41586-020- 2008-3
Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24(6):490–502. doi:10.1016/j. tim.2016.03.003
Woo PCY, Lau SKP, Lam CSF, Lau CCY, Tsang AKL, Lau JHN, et al. Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavi. J. Virol. 2012;86(7):3995–4008. doi:10.1128/ jvi.06540-11
Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020;92(4):418–423. doi:10.1002/jmv.25681
Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17(3):181–192. doi:10.1038/ s41579-018-0118-9
Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg. Microbes Infect. 2020;9(1):558–570. doi:10.1080/2222 1751.2020.1736644
Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, O´- Meara MJ, et al. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug- Repurposing. BioRxiv Prepr. Serv. Biol. 2020;(2020.03.22.002386.). doi:https://doi. org/10.1101/2020.03.22.002386
Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The Architecture of SARS-CoV-2 Transcriptome. Cell. 2020;181(4):914- 921. e10. doi:10.1016/j.cell.2020.04.011
Park YJ, Walls AC, Wang Z, Sauer MM, Li W, Tortorici MA, et. al. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. Nat. Struct. Mol. Biol. 2019;26(12):1151–1157. doi:10.1038/s41594- 019-0334-7
Bosch BJ, van der Zee R, de Haan CAM, Rottier PJM. The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex. J. Virol. 2003;77(16):8801– 8811. doi:10.1128/ jvi.77.16.8801-8811.2003
Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, et al. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell. Mol. Immunol. 2020;17(7):765– 767. doi:10.1038/s41423-020-0374-2
Tang T, Bidon M, Jaimes JA, Whittaker GR, Daniel S. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antiviral Research. 2020;178:104792. doi:10.1016/j. antiviral.2020.104792
Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. doi:10.1126/science.aax0902
Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281-292.e6. doi:10.1016/j. cell.2020.02.058
Gui M, Song W, Zhou H, Xu J, Chen S, Xiang Y, et al. Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding. Cell Res. 2017;27(1):119– 129. doi:10.1038/cr.2016.152
Kirchdoerfer RN, Cottrell CA, Wang N, Pallesen J, Yassine HM, Turner HL, et al. Pre-fusion structure of a human coronavirus spike protein. Nature. 2016;531(7592):118– 121. doi:10.1038/ nature17200
Madu IG, Roth SL, Belouzard S, Whittaker GR. Characterization of a Highly Conserved Domain within the Severe Acute Respiratory Syndrome Coronavirus Spike Protein S2 Domain with Characteristics of a Viral Fusion Peptide. J. Virol. 2009;83(15):7411–7421. doi:10.1128/jvi.00079-09
Millet JK, Whittaker GR. Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Research. 2015;202:120–134. doi:10.1016/j. virusres.2014.11.021
Park JE, Li K, Barlan A, Fehr AR, Perlman S, McCray PB, et al. Proteolytic processing of middle east respiratory syndrome coronavirus spikes expands virus tropism. Proc. Natl. Acad. Sci. U. S. A. 2016;113(43):12262–12267. doi:10.1073/ pnas.1608147113
Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221– 224. doi:10.1038/s41586-020-2179-y
Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS- CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444–1448. doi:10.1126/ science. abb2762
Yurkovetskiy L, Wang X, Pascal KE, Tomkins- Tinch C, Nyalile TP, Wang Y, et al. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant. Cell. 2020;183(3):739-751.e8. doi:10.1016/j. cell.2020.09.032
GISAID - Initiative. Accessed August 23, 2020. https://www.gisaid. org/
GISAID - phylodynamics. Accessed December 22, 2020. Disponible en: www.gisaid.org/ epiflu-applications/ phylodynamics/
Bank RPD. RCSB PDB: Homepage. Accessed December 22, 2020. https://www.rcsb.org/
Isabel S, Graña-Miraglia L, Gutierrez JM, Bundalovic-Torma C, Groves HE, Isabel MR, et al. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide. Sci. Rep. 2020;10(1):1–20. doi:10.1038/ s41598-020- 70827-z
Zhang L, Wang S, Ren Q, Yang J, Lu Y, Zhang L, et al. Genome-wide variations of SARS-CoV-2 infer evolution. MedRxiv Prepr. 2020:1–17. doi: https://doi. org/10.1101/2020.04.27.20081349
Zhang L, Jackson CB, Mou H, Ojha A, Peng H, Quinlan BD, et al. SARS-CoV-2 spike- protein D614G mutation increases virion spike density and infectivity
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Los textos académicos y científicos que se publican en la Revista La Universidad están protegidos bajo la licencia CC BY NC SA 4.0, esta permite usar una obra para crear otra obra o contenido, modificando o no la obra original, siempre que se cite al autor, la obra resultante se comparta bajo el mismo tipo de licencia y no tenga fines comerciales (https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es) . El autor es el único que pose los derechos de publicación y la Revista La Universidad posee los derechos de difusión.